ArticleJournal of clinical monitoring and computing2025
Rapid non-invasive measurement of mitochondrial oxygen tension after microneedle pre-treatment: a feasibility study in human volunteers.
Article in Journal of clinical monitoring and computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Mitochondrial oxygen tension (MitoPO2) is a promising novel non-invasive bedside marker of circulatory shock and is associated with organ failure. The measurement of mitoPO2 requires the topical application of 5-aminolevulinc acid (ALA) to induce sufficient concentrations of the fluorescent protein protoporphyrin-IX within (epi)dermal cells. Currently, its clinical potential in guiding resuscitation therapies is limited by the long induction time prior to obtaining a reliable measurement signal. We investigated whether microneedle pre-treatment of the skin before ALA application allows for earlier measurement of mitoPO2 in healthy human volunteers. 9 healthy human volunteers were included as part of physiological feasibility study. All participants had two ALA-care plasters administered on the chest after cleaning. One part of the skin was pretreated with microneedling, which perforates the epidermis with a depth of 0.30 mm. The time-to-sufficient signal was recorded for both untreated and microneedled ALA-care application. After induction mitoPO2 was varied using different FiO2 and the agreement between untreated and microneedled skin for mitoPO2 and mitoVO2 was recorded. Pre-treatment with microneedling induced reliable signal at 2 (IQR: 2-2) hours after topical ALA administration compared to 3 (IQR: 3-4) hours without pre-treatment (p = 0.02). The intraclass correlation of mitoPO2 simultaneously measured on microneedling and untreated skin was 0.892 (95%CI 0.821-0.936). MitoVO2 showed poor agreement between untreated and microneedling with an ICC of 0.316 (0.04-0.55). We demonstrate that pre-treatment with microneedling before topical application of 5-aminolevulinic acid enables obtaining a reliable and accurate mitoPO2 signal at least an hour faster than on untreated skin in our population of human volunteers. This potentially increases the applicability of mitoPO2 measurements in acute settings.Trial registration number: R21.106 (01-01-2022).
Indexed as
Identifiers
39725811What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.